Ajanta Pharma Limited (AJANTPHARM) — Corporate Action | 30 July 2026(2 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Corporate Action 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Record date set for interim dividend eligibility
💡 Investor Takeaway
Shareholders on record as of August 5, 2026 will receive the interim dividend payout.

Ajanta Pharma announced that August 5, 2026 will be the record date for determining shareholders eligible to receive its first interim dividend, as required under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.

2 Corporate Action 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Board approved 1st interim dividend of Rs. 32 per share (Rs. 400 cr. total) for FY27, payable after 18 August 2026, with record date on 5 August 2026.
🔄 What Changed
Dividend payout of Rs. 400 cr. (Rs. 32/share) and Q1 FY27 revenue growth of 25% to Rs. 1,626 cr. (PAT up 31% to Rs. 334 cr.).
🔮 What's Next
No forward guidance provided in the filing.
💡 Investor Takeaway
The dividend signals strong cash flow and confidence in sustained growth, supporting shareholder returns amid consistent performance across key markets.

Ajanta Pharma announced a 1st interim dividend of Rs. 32 per share (Rs. 400 cr. total) for FY27, payable after 18 August 2026, with record date on 5 August 2026. The Board approved this during its 30 July 2026 meeting, alongside Q1 FY27 results showing 25% revenue growth to Rs. 1,626 cr. and 31% PAT growth to Rs. 334 cr. The company highlighted strong performance across Branded Generics, US Generics, and Africa segments, with Branded Generics contributing 66% of total revenue. The dividend reflects robust cash generation and commitment to shareholder returns amid consistent growth trends.

About Ajanta Pharma Limited (AJANTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹39,694.55 Cr P/E: 37.6 ROE: 23.3% ROCE: 29.4%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AJANTPHARM — Free

Free account · 2 AI queries/day